(Q35753723)

10 August 2017

1 reference

title

Host genetic determinants in hepatitis C virus infection (English)

1 reference

10 August 2017

1 reference

1 reference

Yee LJ

1

1 reference

10 August 2017

1 June 2004

1 reference

10 August 2017

1 reference

10 August 2017

5

1 reference

10 August 2017

237-245

1 reference

10 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gene.6364090

10 August 2017

0 references

cites work

Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Hepatitis C in asymptomatic blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban U.S. population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Clinical outcomes after transfusion-associated hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Association between hepatitis C virus infection and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Porphyria cutanea tarda in Brazilian patients: association with hemochromatosis C282Y mutation and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Autoimmunity and extrahepatic manifestations in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Association of the HLA-DRB1*01 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Interleukin-1, interleukin-10 and tumour necrosis factor-alpha gene polymorphisms in hepatitis C virus infection: an investigation of the relationships with spontaneous viral clearance and response to alpha-interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Viral clearance in hepatitis C (1b) infection: relationship with human leukocyte antigen class II in a homogeneous population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

MHC class II genes influence the susceptibility to chronic active hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Increased frequency of the HLA-DR15 (B1*15011) allele in German patients with self-limited hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Haptoglobin polymorphism and chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Critical role of Val/Gly86 HLA-DRB dimorphism in the neonatal resistance or susceptibility to maternal hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

A p53 polymorphism associated with increased risk of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Racial differences in HLA class II associations with hepatitis C virus outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

HLA-Cw*04 and hepatitis C virus persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Association between Cys282Tyr missense mutation and haptoglobin phenotype polymorphism in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

HLA association with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Absence of association between HLA antigens and chronicity of viral hepatitis in haemodialyzed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Polymorphisms in the interleukin-10, tumor necrosis factor-alpha, and transforming growth factor-beta1 genes in chronic hepatitis C patients treated with interferon and ribavirin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

HLA class II genotypes associated with chronic hepatitis C virus infection and response to alpha-interferon treatment in Poland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Decreased frequency of the HLA-DRB1*11 allele in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

MHC and the viral hepatitides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

21 January 2018

Meta-Analysis in Stata™

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

HCV chronic infection and CCR5-delta32/delta32.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

High frequency of CCR5-delta32 homozygosity in HCV-infected, HIV-1-uninfected hemophiliacs results from resistance to HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Study of the association between major histocompatibility complex class II genes and the response to interferon alpha in patients with chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Interferon-alpha therapy in HCV hepatitis: HLA phenotype and cirrhosis are independent predictors of clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

C-C chemokine receptor 2 and C-C chemokine receptor 5 genotypes in patients treated for chronic hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Human leukocyte antigen DRB1 1302 protects against bile duct damage and portal lymphocyte infiltration in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

HFE gene mutations prevent sustained virological response to interferon plus ribavirin in chronic hepatitis C patients with serum markers of iron overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt -88) correlated with the response of hepatitis C patients to interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Genetic polymorphism of the MxA gene promoter and interferon responsiveness of hepatitis C patients: revisited by analyzing two SNP sites (-123 and -88) in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Hepatitis C virus infection and mutations of mannose-binding lectin gene MBL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Association of mannose-binding lectin gene haplotype LXPA and LYPB with interferon-resistant hepatitis C virus infection in Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Possible association between HLA antigens and the response to interferon in Japanese patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Association of HLA Alleles with Response (Especially Biochemical Response) to Interferon Therapy in Japanese Patients with Chronic Hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Iron deposition and progression of disease in chronic hepatitis C. Role of interface hepatitis, portal inflammation, and HFE missense mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

A single nucleotide polymorphism of the low molecular mass polypeptide 7 gene influences the interferon response in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Association ofCTLA4Polymorphisms with Sustained Response to Interferon and Ribavirin Therapy for Chronic Hepatitis C Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Differential regulation of interleukin-10 production by genetic and environmental factors--a twin study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Risk factors of hepatitis C virus-related liver cirrhosis in young adults: positive family history of liver disease and transporter associated with antigen processing 2(TAP2)*0201 Allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Human leukocyte antigen DR markers as predictors of progression to liver transplantation in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Involvement of transporter associated with antigen processing 2 (TAP2) gene polymorphisms in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Are haemochromatosis mutations related to the severity of liver disease in hepatitis C virus infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Host genetic factors influence disease progression in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

A genotypic association implicates myeloperoxidase in the progression of hepatic fibrosis in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Influence of TNF gene polymorphism and HLA-DRB1 haplotype in Japanese patients with chronic liver disease caused by HCV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Hemochromatosis gene modifies course of hepatitis C viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Are HLA class II and immunoglobulin constant region genes involved in the pathogenesis of mixed cryoglobulinemia type II after hepatitis C virus infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Genetic predispositions for the presence of cryoglobulinemia and serum autoantibodies in Chinese patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Autoimmune hepatitis type 2 and hepatitis C virus infection: study of HLA antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Iron enhances hepatitis C virus replication in cultured human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

The association between rheumatoid arthritis and the HLA antigen DR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Association of MHC and rheumatoid arthritis. Association of RA with HLA-DR4: the role of repertoire selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Unlocking the mysteries of virus-host interactions: does functional genomics hold the key?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

The importance of assessing effect modification when asserting racial differences in associations between human leukocyte antigen class II alleles and hepatitis C virus outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Control of confounding of genetic associations in stratified populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Mapping genes that underlie ethnic differences in disease risk: methods for detecting linkage in admixed populations, by conditioning on parental admixture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Epidemiological methods for studying genes and environmental factors in complex diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

HLA DR13 and HCV vertical infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Association between MHC Class II Alleles and Clearance of Circulating Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Hemochromatosis Cys282Tyr mutation and liver iron overload in patients with chronic active hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

Rheumatic disorders associated with hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

7 January 2021

No significant influence of HLA determinants on susceptibility to hepatitis C virus infection in Caucasian patients with end-stage renal disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

7 January 2021

Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

7 January 2021

HLA class II favors clearance of HCV infection and progression of the chronic liver damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

7 January 2021

The MHC is a major determinant of viral status, but not fibrotic stage, in individuals infected with hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

7 January 2021

HLA antigens in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

7 January 2021

HLA typing in chronic type B, D and C hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

7 January 2021

Discussion on frequency of the HIV-protective CC chemokine receptor 5-Δ32/Δ32 genotype is increased in hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

7 January 2021

Frequency of the 32-base pair deletion in the chemokine receptor CCR5 gene is not increased in hepatitis C patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

7 January 2021

Genes of major histocompatibility complex class II influence chronic C hepatitis treatment with interferon in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

7 January 2021

Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

7 January 2021

HLA class II genes determine the natural variance of hepatitis C viral load

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

7 January 2021

The effect of HLA alleles on response to interferon therapy in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

7 January 2021

The dinucleotide microsatellite polymorphism of the IFNAR1 gene promoter correlates with responsiveness of hepatitis C patients to interferon

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

7 January 2021

Response to interferon therapy: influence of human leucocyte antigen alleles in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

7 January 2021

HLA DRB1 and DQB1 alleles and haplotypes influencing the progression of hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

7 January 2021

DR human leukocyte antigens and disease severity in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

7 January 2021

Analysis of HLA alleles in Japanese patients with cirrhosis due to chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

7 January 2021

Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

7 January 2021

Hemochromatosis mutation in hepatitis C: histopathology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

7 January 2021

The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

7 January 2021

B and C hepatitis viruses, HLA-DQ1 and -DR3 alleles and autoimmunity in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

7 January 2021

The role of liver biopsy in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

7 January 2021

Genetic predispositions for immunological features in chronic liver diseases other than autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

7 January 2021

CYP2D6 polymorphism and the presence of anti-LKM-1 in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

7 January 2021

HLA antigens in patients with interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

7 January 2021

Genetic predispositions for the immunological features of chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364090

7 January 2021

Identifiers

DOI

10.1038/SJ.GENE.6364090

1 reference

10 August 2017

1 reference

PubMed ID

15103322